Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia

Lymphoplasmacytic lymphoma (LPL) is a rare subtype of B cell-derived non-Hodgkin lymphoma characterized by the abnormal growth of transformed clonal lymphoplasmacytes and plasma cells. This tumor almost always displays the capability of secreting large amounts of monoclonal immunoglobulins (Ig) of t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Francesco Piazza, Veronica Di Paolo, Greta Scapinello, Sabrina Manni, Livio Trentin, Luigi Quintieri
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-01-01
coleção:	Frontiers in Oncology
Assuntos:	lymphoplasmacytic lymphoma Waldenström macroglobulinaemia drug resistance MyD88 CXCR4 Bruton’s tyrosine kinase
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2021.801124/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!